...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Exploration of potential prodrug approach of the bis-thiazolium salts T3 and T4 for orally delivered antimalarials.
【24h】

Exploration of potential prodrug approach of the bis-thiazolium salts T3 and T4 for orally delivered antimalarials.

机译:探索双噻唑盐T3和T4用于口服抗疟药的潜在前药方法。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We report here the synthesis and biological evaluation of a series of 37 compounds as precursors of potent antimalarial bis-thiazolium salts (T3 and T4). These prodrugs were either thioester, thiocarbonate or thiocarbamate type and were synthesized in one step by reaction of an alkaline solution of the parent drug with the appropriate activated acyl group. Structural variations affecting physicochemical properties were made in order to improve oral activity. Twenty-five of them exhibited potent antimalarial activity with IC(50) lower than 7nM against Plasmodium falciparum in vitro. Notably, 3 and 22 showed IC(50)=2.2 and 1.8nM, respectively. After oral administration 22 was the most potent compound clearing the parasitemia in Plasmodium vinckei infected mice with a dose of 1.3mg/kg.
机译:我们在这里报告了作为有效抗疟药双噻唑鎓盐(T3和T4)的前体的一系列37种化合物的合成和生物学评估。这些前药是硫代酯,硫代碳酸酯或硫代氨基甲酸酯类型,是通过母体药物的碱性溶液与适当的活化酰基反应而一步合成的。为了改善口服活性,进行了影响理化性质的结构变化。其中有25个在体外对恶性疟原虫表现出有效的抗疟活性,IC(50)低于7nM。值得注意的是,3和22分别显示IC(50)= 2.2和1.8nM。口服后,剂量为1.3mg / kg的22种化合物能最有效地清除温氏疟原虫感染小鼠的寄生虫病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号